Lumexa Imaging Holdings, Inc. Common Stock
LMRINASDAQHealthcare● Active
$8.24
$-0.26(-3.05%)
Market Cap$791772513
P/E Ratio—
52W High$19.45
52W Low$6.45
Lumexa Imaging Holdings, Inc. Common Stock（LMRI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · LMRI · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 |
|---|---|---|---|
| Revenue | |||
| Revenue | $1.02B | $0.95B | $0.94B |
| Cost of Revenue | $0.91B | $0.85B | $0.84B |
| Gross Profit | $0.12B | $0.10B | $0.10B |
| Gross Margin %(computed) | 11.45% | 10.15% | 10.57% |
| Operating Expenses | |||
| R&D Expenses | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.09B | $0.07B | $0.06B |
| Total Operating Expenses | $0.09B | $0.04B | $0.08B |
| Operating Income | $0.03B | $0.06B | $0.02B |
| Operating Margin %(computed) | 2.61% | 5.82% | 2.40% |
| Interest Income | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.12B | $0.14B | $0.14B |
| Income Before Tax | ($0.03B) | ($0.08B) | ($0.12B) |
| Income Tax Expense | $0.01B | $0.01B | $0.00B |
| Net Income | ($0.05B) | ($0.09B) | ($0.12B) |
| Net Margin %(computed) | -4.60% | -9.92% | -13.06% |
| Per Share & EBITDA | |||
| EPS (Basic) | $-0.66 | $-1.00 | $-1.29 |
| Wtd Avg Shares | 0.07B | 0.09B | 0.09B |
| EBITDA | $0.08B | $0.11B | $0.09B |
| EBITDA Margin %(computed) | 8.03% | 12.01% | 10.11% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-08 · USD · B
深入了解Lumexa Imaging Holdings, Inc. Common Stock
关于Lumexa Imaging Holdings, Inc. Common Stock（LMRI）损益表
Lumexa Imaging Holdings, Inc. Common Stock（LMRI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，LMRI实现营收$1.02B，毛利润$0.12B（毛利率11.45%），净利润($0.05B)（净利率-4.60%）。
常见问题
LMRI · 4 问Lumexa Imaging Holdings, Inc. Common Stock（LMRI）2025财年营收为$1.02B，同比up7.8%。
LMRI revenueLMRI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08